BioSpace News Archive

Surge in initiatives by several government bodies to reduce the healthcare costs is projected to translate into extensive growth prospects for companies operating in the global long-term care software market during the forecast period between 2021 and 2031.

Alentis Therapeutics, the Swiss biotech developing breakthrough treatments for fibrotic diseases, announced the appointments of Luca Santarelli, M.D. as independent Non-Executive Director, and Rafaèle Tordjman, M.D. PhD as Chairperson of its Board of Directors, with immediate effect.

Kernal Biologics, Inc. — an early-development-stage mRNA-technology company developing cancer therapeutics designed to improve patients’ survival rate and quality of life — is in Berlin, Germany, at the 9th Annual International mRNA Health Conference through tomorrow, November 10, 2021, presenting eagerly anticipated results from two preclinical studies.

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces its financial results for the three months ended September 30, 2021, and provides a corporate update.

Osteopore, an Australian and Singapore based leader in regenerative implants on a commercial scale, is developing technology that enables widespread adoption of tissue engineering.

CN Bio, a leading Organ-on-a-chip Company that designs and manufactures single- and multi-organ microphysiological systems, announced a research collaboration with the Infection Innovation Consortium, a global collaborative infectious disease R&D programme, to validate the next generation of COVID-19 research tools.

Artificial intelligence tools and technologies have been making enormous impacts on various aspects of healthcare.

The current generation of infusion pumps is current equipped with software to control the entire pumping mechanism, with the dual objective of safety and ease-of-use.

The veterinary drugs market is prognosticated to observe considerable growth during the forecast period of 2016-2024.

Innate Pharma SA, announced that the Company will hold a conference call on Tuesday, November 16, 2021, at 2 p.m. CET / 8 a.m. ET, to give an update on business progress during the third quarter of 2021.